Skip to main content
GaldermaPatent grant

Galderma was granted a patent for acylated glycosaminoglycan hydrogels

Source: Autobound Signal API · 72 signals tracked for Galderma · updated

Get Galderma's live signals in Claude or ChatGPT, or by API

AskWhat changed at Galderma this week? Use Autobound signals for galderma.com.

What happened

In November 2026 Galderma patented a method for preparing crosslinked glycosaminoglycan hydrogels for injectable and topical aesthetic or dermatological products.

Source

patents.google.comNov 10, 2026

US patent US12790447

Method for preparing acylated crosslinked glycosaminoglycans

Abstract

A method of preparing a hydrogel product including crosslinked glycosaminoglycan molecules, said method including: i) providing a glycosaminoglycan crosslinked by amide bonds, wherein the crosslinked glycosaminoglycans include residual amine groups; and ii) acylating residual amine groups of the crosslinked glycosaminoglycans provided in i) to form acylated crosslinked glycosaminoglycans.

patents.google.com/patent/US12790447Read the full source

Extracted by Autobound

From the Signal API record
Signal
Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Grant date
Nov 10, 2026
Inventors
Johan Olsson, Craig Steven Harris
Patent number
US12790447
Assignee
Galderma Holding SA

The full record

From the Signal API record

People

  • Johan OlssonInventor
  • Craig Steven HarrisInventor

Details

Primary CPC class
C08J 3/075
USPTO assignee
Galderma Holding SA
What the invention does
A process that crosslinks glycosaminoglycan molecules and then chemically modifies leftover amine groups to create a tailored gel material.

Topics and mentions

Tags

  • Intellectual Property
  • Research & Development
  • Chemical Engineering
  • Healthcare Technology

Technologies named

  • hydrogels
  • glycosaminoglycans
  • polymer chemistry

Extraction

Detected
Nov 11, 2026
signal_type
patents-company
signal_subtype
patentGrant

Use this data

Get every patent signal for Galderma and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Galderma this week?”

  2. Send it to your own tools

    The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/6d43f075-edc5-5256-b9ca-3907ff34ff9f returns this record as JSON. POST /v1/companies/enrich returns every signal for galderma.com.

{
  "signal_id": "6d43f075-edc5-5256-b9ca-3907ff34ff9f",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-11-11T15:23:07+00:00",
  "company": {
    "name": "Galderma",
    "domain": "galderma.com"
  },
  "data": {
    "cpc": [
      {
        "code": "C08J 3/075"
      },
      {
        "code": "A61K 8/042"
      },
      {
        "code": "A61K 8/73"
      },
      {
        "code": "A61K 8/735"
      },
      {
        "code": "A61K 9/0019"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Chemical Engineering",
      "Healthcare Technology"
    ],
    "detail": "In November 2026 Galderma patented a method for preparing crosslinked glycosaminoglycan hydrogels for injectable and topical aesthetic or dermatological products.",
    "summary": "Galderma was granted a patent for acylated glycosaminoglycan hydrogels",
    "event_at": "2026-11-10",
    "inventors": [
      {
        "name": "Johan Olsson",
        "status": "unresolved",
        "is_primary": true
      },
      {
        "name": "Craig Steven Harris",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-11-10",
    "source_url": "https://patents.google.com/patent/US12790447",
    "cpc_primary": {
      "code": "C08J 3/075"
    },
    "patent_title": "Method for preparing acylated crosslinked glycosaminoglycans",
    "patent_number": "US12790447",
    "uspto_assignee": "Galderma Holding SA",
    "patent_abstract": "A method of preparing a hydrogel product including crosslinked glycosaminoglycan molecules, said method including: i) providing a glycosaminoglycan crosslinked by amide bonds, wherein the crosslinked glycosaminoglycans include residual amine groups; and ii) acylating residual amine groups of the crosslinked glycosaminoglycans provided in i) to form acylated crosslinked glycosaminoglycans.",
    "precision_class": "structural",
    "invention_explanation": "A process that crosslinks glycosaminoglycan molecules and then chemically modifies leftover amine groups to create a tailored gel material.",
    "technologies_mentioned": [
      "hydrogels",
      "glycosaminoglycans",
      "polymer chemistry"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.